The agreement is about the registration and distribution of the aforementioned vaccines in the Mexican market, which is one of the largest markets in Latin America in terms of influenza vaccines — about 35 million doses of influenza vaccines are applied annually in Mexico.
The purpose of this collaboration is to continue promoting the culture of health through the timely application of flu vaccines recognized and widely applied in Russia, Nicaragua, Venezuela and Cuba.
The entry into the Mexican market of vaccines produced at the MECHNIKOV Institute will significantly expand the country's immunization coverage and increase the level of protection of the population against seasonal influenza.